(MENAFN- Live Mint) From Indian stock market indices suffering significant losses, to Covid-like HMPV virus wreaking havoc in China, actor Allu Arjun getting bail - we bring you a glimpse of the top stories on January 3.
Stock market crash
Indian Stock market benchmarks-the Sensex and the Nifty 50-suffered significant losses on Friday, January 3, due to profit booking amid the strengthening US dollar.
Also Read | THESE equity mutual funds across market caps delivered highest returns in 2024
The BSE benchmark Sensex opened at 80,072.99 against its previous close of 79,943.71 and fell 834 points to an intra-day low of 79,109.73. However, the 30-pack index recouped some losses and closed 721 points, or 0.90 per cent, down at 79,223.11.
China COVID-like HMPV virus outbreak
A virus, called human metapneumovirus (HMPV), has been spreading in China. The country reported rising cases of HMPV, especially among those under 14 in northern provinces, reported Reuters.
Speaking to Livemint, several doctors said that the HMPV virus has symptoms very similar to that of the COVID-19 virus. Precautionary measures such as wearing masks in crowded areas, avoiding close contact, can help reduce the risk of contracting HMPV.
Allu Arjun gets bail
In a major relief for Pushpa 2 actor Allu Arjun, Hyderabad's Nampally court has granted him a regular bail in stampede case. Allu Arjun has been granted bail on two sureties bond of worth ₹50,000 each.
Also Read | Allu Arjun movie's gold rush slows down, Pushpa 2 mints ₹2.05 crore on Friday
“He (Allu Arjun) has to execute ₹50,000 with two sureties and has to visit the police station every Sunday,” Ashok Reddy, advocate for Allu Arjun said. The stampede happened on December 4, just a day before 'Pushpa 2: The Rule's' official release in the theatres.
MENAFN03012025007365015876ID1109052629
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.